Project
PRJEB1986: zebrafish developmental stages transcriptome
Navigation
Downloads
Results for snai1a
Z-value: 4.71
Motif logo
Transcription factors associated with snai1a
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
snai1a
|
ENSDARG00000056995 | snail family zinc finger 1a |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| snai1a | dr11_v1_chr11_-_25257595_25257595 | -0.97 | 9.2e-12 | Click! |
Activity profile of snai1a motif
Sorted Z-values of snai1a motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr11_-_101758 | 42.67 |
ENSDART00000173015
|
elmo2
|
engulfment and cell motility 2 |
| chr18_+_907266 | 20.39 |
ENSDART00000171729
|
pkma
|
pyruvate kinase M1/2a |
| chr9_-_22310919 | 19.18 |
ENSDART00000108719
|
crygm2d10
|
crystallin, gamma M2d10 |
| chr2_+_15612755 | 17.54 |
ENSDART00000003035
|
amy2a
|
amylase, alpha 2A (pancreatic) |
| chr18_-_5781922 | 16.46 |
ENSDART00000128722
|
RGS9BP
|
si:ch73-167i17.6 |
| chr19_+_233143 | 16.21 |
ENSDART00000175273
|
syngap1a
|
synaptic Ras GTPase activating protein 1a |
| chr21_+_11468934 | 16.04 |
ENSDART00000126045
ENSDART00000129744 ENSDART00000102368 |
grin1a
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1a |
| chr19_-_27966526 | 15.47 |
ENSDART00000141896
|
ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
| chr23_+_17387325 | 15.38 |
ENSDART00000083947
|
ptk6b
|
PTK6 protein tyrosine kinase 6b |
| chr9_-_44948488 | 15.12 |
ENSDART00000059228
|
vil1
|
villin 1 |
| chr19_-_27966780 | 15.03 |
ENSDART00000110016
|
ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
| chr9_-_22182396 | 14.43 |
ENSDART00000101809
|
crygm2d6
|
crystallin, gamma M2d6 |
| chr20_-_52902693 | 14.23 |
ENSDART00000166115
ENSDART00000161050 |
ctsbb
|
cathepsin Bb |
| chr8_-_11112058 | 14.19 |
ENSDART00000042755
|
ampd1
|
adenosine monophosphate deaminase 1 (isoform M) |
| chr20_-_29420713 | 13.92 |
ENSDART00000147464
|
ryr3
|
ryanodine receptor 3 |
| chr4_-_68563862 | 13.86 |
ENSDART00000182970
|
BX548011.2
|
|
| chr3_+_32526799 | 13.75 |
ENSDART00000185755
|
si:ch73-367p23.2
|
si:ch73-367p23.2 |
| chr25_-_169291 | 13.30 |
ENSDART00000128344
|
lipcb
|
lipase, hepatic b |
| chr9_-_22281854 | 12.98 |
ENSDART00000146319
|
crygm2d3
|
crystallin, gamma M2d3 |
| chr22_+_7439476 | 12.96 |
ENSDART00000021594
ENSDART00000063389 |
zgc:92041
|
zgc:92041 |
| chr25_-_207214 | 12.23 |
ENSDART00000193448
|
FP236318.3
|
|
| chr9_-_22240052 | 12.18 |
ENSDART00000111109
|
crygm2d9
|
crystallin, gamma M2d9 |
| chr8_+_6954984 | 12.06 |
ENSDART00000145610
|
si:ch211-255g12.6
|
si:ch211-255g12.6 |
| chr9_-_22232902 | 11.90 |
ENSDART00000101845
|
crygm2d5
|
crystallin, gamma M2d5 |
| chr21_+_11468642 | 11.51 |
ENSDART00000041869
|
grin1a
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1a |
| chr3_+_16612574 | 11.50 |
ENSDART00000104481
|
slc17a7a
|
solute carrier family 17 (vesicular glutamate transporter), member 7a |
| chr25_-_16589461 | 11.47 |
ENSDART00000064204
|
cpa4
|
carboxypeptidase A4 |
| chr16_+_12022543 | 10.96 |
ENSDART00000012673
|
gnb3a
|
guanine nucleotide binding protein (G protein), beta polypeptide 3a |
| chr19_-_12324514 | 10.88 |
ENSDART00000122192
|
ncaldb
|
neurocalcin delta b |
| chr6_+_3827751 | 10.79 |
ENSDART00000003008
ENSDART00000122348 |
gad1b
|
glutamate decarboxylase 1b |
| chr22_-_29336268 | 10.74 |
ENSDART00000132776
ENSDART00000186351 ENSDART00000121599 |
pdgfba
|
platelet-derived growth factor beta polypeptide a |
| chr9_-_42861080 | 10.70 |
ENSDART00000193688
|
ttn.1
|
titin, tandem duplicate 1 |
| chr9_-_22158784 | 10.59 |
ENSDART00000167850
|
crygm2d14
|
crystallin, gamma M2d14 |
| chr7_+_35068036 | 10.42 |
ENSDART00000022139
|
zgc:136461
|
zgc:136461 |
| chr4_-_77557279 | 10.33 |
ENSDART00000180113
|
AL935186.10
|
|
| chr7_-_35066457 | 10.30 |
ENSDART00000058067
|
zgc:112160
|
zgc:112160 |
| chr14_+_15155684 | 10.20 |
ENSDART00000167966
|
zgc:158852
|
zgc:158852 |
| chr14_+_22172047 | 9.84 |
ENSDART00000114750
ENSDART00000148259 |
gabrb2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
| chr6_+_4872883 | 9.62 |
ENSDART00000186730
ENSDART00000092290 ENSDART00000151674 |
pcdh9
|
protocadherin 9 |
| chr7_+_39446247 | 9.54 |
ENSDART00000033610
ENSDART00000099015 |
tnnt3b
|
troponin T type 3b (skeletal, fast) |
| chr24_-_25574967 | 9.50 |
ENSDART00000189828
|
cnksr2a
|
connector enhancer of kinase suppressor of Ras 2a |
| chr9_-_22099536 | 9.37 |
ENSDART00000101923
|
CR391987.1
|
|
| chr23_+_39854566 | 9.35 |
ENSDART00000190423
ENSDART00000164473 ENSDART00000161881 |
si:ch73-217b7.1
|
si:ch73-217b7.1 |
| chr19_+_206835 | 9.35 |
ENSDART00000161137
|
scn1bb
|
sodium channel, voltage-gated, type I, beta b |
| chr14_-_4556896 | 9.29 |
ENSDART00000044678
ENSDART00000192863 |
GABRA2
|
gamma-aminobutyric acid type A receptor alpha2 subunit |
| chr15_-_43164591 | 9.29 |
ENSDART00000171305
|
ap1s3a
|
adaptor-related protein complex 1, sigma 3 subunit, a |
| chr8_-_21184759 | 9.27 |
ENSDART00000139257
|
gls2a
|
glutaminase 2a (liver, mitochondrial) |
| chr2_+_22702488 | 9.27 |
ENSDART00000076647
|
kif1ab
|
kinesin family member 1Ab |
| chr25_+_7982979 | 9.20 |
ENSDART00000171904
|
ucmab
|
upper zone of growth plate and cartilage matrix associated b |
| chr3_+_32526263 | 9.02 |
ENSDART00000150897
|
si:ch73-367p23.2
|
si:ch73-367p23.2 |
| chr25_-_4482449 | 9.01 |
ENSDART00000056278
ENSDART00000149425 |
slc25a22a
|
solute carrier family 25 member 22a |
| chr15_+_21862295 | 8.98 |
ENSDART00000154449
ENSDART00000180774 |
si:dkey-103g5.3
|
si:dkey-103g5.3 |
| chr8_-_52413032 | 8.88 |
ENSDART00000183039
|
CABZ01070469.1
|
|
| chr1_+_8662530 | 8.78 |
ENSDART00000054989
|
fscn1b
|
fascin actin-bundling protein 1b |
| chr16_-_17207754 | 8.67 |
ENSDART00000063804
|
wu:fj39g12
|
wu:fj39g12 |
| chr23_-_27571667 | 8.66 |
ENSDART00000008174
|
pfkma
|
phosphofructokinase, muscle a |
| chr15_-_576135 | 8.62 |
ENSDART00000124170
|
cbln20
|
cerebellin 20 |
| chr21_-_28340977 | 8.61 |
ENSDART00000141629
|
nrxn2a
|
neurexin 2a |
| chr5_+_37837245 | 8.59 |
ENSDART00000171617
|
epd
|
ependymin |
| chr21_-_2287589 | 8.56 |
ENSDART00000161554
|
si:ch73-299h12.4
|
si:ch73-299h12.4 |
| chr1_+_12135129 | 8.53 |
ENSDART00000126020
|
spink4
|
serine peptidase inhibitor, Kazal type 4 |
| chr23_-_3674443 | 8.49 |
ENSDART00000134830
ENSDART00000057422 |
pacsin1a
|
protein kinase C and casein kinase substrate in neurons 1a |
| chr7_-_38638809 | 8.45 |
ENSDART00000144341
|
c6ast4
|
six-cysteine containing astacin protease 4 |
| chr2_+_45696743 | 8.41 |
ENSDART00000114225
ENSDART00000169279 |
CU467828.1
|
|
| chr16_+_52512025 | 8.38 |
ENSDART00000056095
|
fabp10a
|
fatty acid binding protein 10a, liver basic |
| chr22_+_7439186 | 8.34 |
ENSDART00000190667
|
zgc:92041
|
zgc:92041 |
| chr19_+_8506178 | 8.30 |
ENSDART00000189689
|
s100a10a
|
S100 calcium binding protein A10a |
| chr23_+_28648864 | 8.30 |
ENSDART00000189096
|
l1cama
|
L1 cell adhesion molecule, paralog a |
| chr22_+_7480465 | 8.29 |
ENSDART00000034545
|
CELA1 (1 of many)
|
zgc:92745 |
| chr9_-_42873700 | 8.29 |
ENSDART00000125953
|
ttn.1
|
titin, tandem duplicate 1 |
| chr16_-_26074529 | 8.24 |
ENSDART00000148653
ENSDART00000148923 |
tmem145
|
transmembrane protein 145 |
| chr15_-_37850969 | 8.23 |
ENSDART00000031418
|
hsc70
|
heat shock cognate 70 |
| chr2_-_32643738 | 8.18 |
ENSDART00000112452
|
si:dkeyp-73d8.9
|
si:dkeyp-73d8.9 |
| chr14_-_46238186 | 8.17 |
ENSDART00000173245
|
si:ch211-113d11.6
|
si:ch211-113d11.6 |
| chr12_+_13244149 | 8.14 |
ENSDART00000186984
ENSDART00000105896 |
atp2a1l
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1, like |
| chr20_+_50115335 | 8.11 |
ENSDART00000031139
|
slc24a4b
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4b |
| chr6_+_42918933 | 8.10 |
ENSDART00000064896
|
gnat1
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
| chr9_-_22213297 | 8.10 |
ENSDART00000110656
ENSDART00000133149 |
crygm2d20
|
crystallin, gamma M2d20 |
| chr17_-_37395460 | 8.09 |
ENSDART00000148160
ENSDART00000075975 |
crip1
|
cysteine-rich protein 1 |
| chr9_-_22299412 | 8.07 |
ENSDART00000139101
|
crygm2d21
|
crystallin, gamma M2d21 |
| chr20_-_18915376 | 7.96 |
ENSDART00000063725
|
xkr6b
|
XK, Kell blood group complex subunit-related family, member 6b |
| chr5_-_30620625 | 7.91 |
ENSDART00000098273
|
tcnl
|
transcobalamin like |
| chr17_+_27456804 | 7.90 |
ENSDART00000017756
ENSDART00000181461 ENSDART00000180178 |
ctsl.1
|
cathepsin L.1 |
| chr4_-_53370 | 7.90 |
ENSDART00000180254
ENSDART00000186529 |
CU856344.2
|
|
| chr11_+_25472758 | 7.85 |
ENSDART00000011178
|
opn1sw2
|
opsin 1 (cone pigments), short-wave-sensitive 2 |
| chr8_+_24861264 | 7.82 |
ENSDART00000099607
|
slc6a17
|
solute carrier family 6 (neutral amino acid transporter), member 17 |
| chr8_+_46939391 | 7.81 |
ENSDART00000146631
|
espn
|
espin |
| chr20_+_54336137 | 7.80 |
ENSDART00000113792
|
cipcb
|
CLOCK-interacting pacemaker b |
| chr1_+_53321878 | 7.76 |
ENSDART00000143909
|
tbc1d9
|
TBC1 domain family, member 9 (with GRAM domain) |
| chr16_-_19890303 | 7.66 |
ENSDART00000147161
ENSDART00000079159 |
hdac9b
|
histone deacetylase 9b |
| chr11_-_43104475 | 7.61 |
ENSDART00000125368
|
acyp2
|
acylphosphatase 2, muscle type |
| chr8_+_1651821 | 7.56 |
ENSDART00000060865
ENSDART00000186304 |
rasal1b
|
RAS protein activator like 1b (GAP1 like) |
| chr25_+_31222069 | 7.54 |
ENSDART00000159373
|
tnni2a.1
|
troponin I type 2a (skeletal, fast), tandem duplicate 1 |
| chr16_-_36834505 | 7.52 |
ENSDART00000141275
ENSDART00000139588 ENSDART00000041993 |
pnp4b
|
purine nucleoside phosphorylase 4b |
| chr20_-_791788 | 7.52 |
ENSDART00000134128
|
impg1a
|
interphotoreceptor matrix proteoglycan 1a |
| chr6_-_345503 | 7.50 |
ENSDART00000168901
|
pde6ha
|
phosphodiesterase 6H, cGMP-specific, cone, gamma, paralog a |
| chr24_-_14711597 | 7.43 |
ENSDART00000131830
|
jph1a
|
junctophilin 1a |
| chr6_-_16667886 | 7.41 |
ENSDART00000180854
ENSDART00000190116 |
unc80
|
unc-80 homolog (C. elegans) |
| chr6_-_607063 | 7.40 |
ENSDART00000189900
|
lgals2b
|
lectin, galactoside-binding, soluble, 2b |
| chr2_-_22688651 | 7.37 |
ENSDART00000013863
|
agxtb
|
alanine-glyoxylate aminotransferase b |
| chr11_-_669270 | 7.36 |
ENSDART00000172834
|
pparg
|
peroxisome proliferator-activated receptor gamma |
| chr12_-_17810543 | 7.36 |
ENSDART00000090484
|
tecpr1a
|
tectonin beta-propeller repeat containing 1a |
| chr7_+_36539124 | 7.34 |
ENSDART00000173653
|
chd9
|
chromodomain helicase DNA binding protein 9 |
| chr1_-_21909608 | 7.33 |
ENSDART00000139937
|
frmpd1a
|
FERM and PDZ domain containing 1a |
| chr3_+_18097700 | 7.26 |
ENSDART00000021634
|
wfikkn2a
|
info WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2a |
| chr5_-_32092856 | 7.19 |
ENSDART00000086181
ENSDART00000181677 |
cabp7b
|
calcium binding protein 7b |
| chr9_-_46382637 | 7.17 |
ENSDART00000085738
|
lct
|
lactase |
| chr2_+_52232630 | 7.11 |
ENSDART00000006216
|
plpp2a
|
phospholipid phosphatase 2a |
| chr12_-_22524388 | 7.09 |
ENSDART00000020942
|
shbg
|
sex hormone-binding globulin |
| chr6_+_55277419 | 7.09 |
ENSDART00000083670
|
CABZ01041604.1
|
|
| chr23_-_44219902 | 7.09 |
ENSDART00000185874
|
zgc:158659
|
zgc:158659 |
| chr7_-_32599669 | 7.08 |
ENSDART00000173752
|
kcna4
|
potassium voltage-gated channel, shaker-related subfamily, member 4 |
| chr8_+_1187928 | 7.05 |
ENSDART00000127252
|
slc35d2
|
solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 |
| chr1_+_2712956 | 7.04 |
ENSDART00000126093
|
gpc6a
|
glypican 6a |
| chr10_+_32561317 | 7.03 |
ENSDART00000109029
|
map6a
|
microtubule-associated protein 6a |
| chr20_+_42978499 | 7.02 |
ENSDART00000138793
|
si:ch211-203k16.3
|
si:ch211-203k16.3 |
| chr25_-_13614702 | 7.02 |
ENSDART00000165510
ENSDART00000190959 |
fa2h
|
fatty acid 2-hydroxylase |
| chr11_-_37509001 | 7.00 |
ENSDART00000109753
|
bsnb
|
bassoon (presynaptic cytomatrix protein) b |
| chr11_-_11266882 | 7.00 |
ENSDART00000020256
|
lgsn
|
lengsin, lens protein with glutamine synthetase domain |
| chr14_-_48588422 | 7.00 |
ENSDART00000161147
|
si:ch211-154c21.1
|
si:ch211-154c21.1 |
| chr4_-_8040436 | 6.99 |
ENSDART00000113033
|
si:ch211-240l19.6
|
si:ch211-240l19.6 |
| chr3_-_61205711 | 6.98 |
ENSDART00000055062
|
pvalb1
|
parvalbumin 1 |
| chr5_-_30615901 | 6.97 |
ENSDART00000147769
|
si:ch211-117m20.5
|
si:ch211-117m20.5 |
| chr1_-_44084071 | 6.95 |
ENSDART00000166912
|
vwa11
|
von Willebrand factor A domain containing 11 |
| chr3_-_1317290 | 6.94 |
ENSDART00000047094
|
LO018552.1
|
|
| chr6_-_609880 | 6.94 |
ENSDART00000149248
ENSDART00000148867 ENSDART00000149414 ENSDART00000148552 ENSDART00000148391 |
lgals2b
|
lectin, galactoside-binding, soluble, 2b |
| chr18_-_40684756 | 6.92 |
ENSDART00000113799
ENSDART00000139042 |
si:ch211-132b12.7
|
si:ch211-132b12.7 |
| chr22_+_17359346 | 6.91 |
ENSDART00000145434
|
gpr52
|
G protein-coupled receptor 52 |
| chr21_+_45839917 | 6.90 |
ENSDART00000189305
|
faxdc2
|
fatty acid hydroxylase domain containing 2 |
| chr25_-_17395315 | 6.84 |
ENSDART00000064596
|
cyp2x8
|
cytochrome P450, family 2, subfamily X, polypeptide 8 |
| chr23_-_39666519 | 6.83 |
ENSDART00000110868
ENSDART00000190961 |
vwa1
|
von Willebrand factor A domain containing 1 |
| chr15_-_47193564 | 6.82 |
ENSDART00000172453
|
LSAMP
|
limbic system-associated membrane protein |
| chr2_-_22152797 | 6.78 |
ENSDART00000145188
|
cyp7a1
|
cytochrome P450, family 7, subfamily A, polypeptide 1 |
| chr13_+_33703784 | 6.77 |
ENSDART00000173361
|
macrod2
|
MACRO domain containing 2 |
| chr17_+_10566490 | 6.77 |
ENSDART00000144408
ENSDART00000137469 |
mgaa
|
MGA, MAX dimerization protein a |
| chr17_-_52595932 | 6.71 |
ENSDART00000127225
|
si:ch211-173a9.7
|
si:ch211-173a9.7 |
| chr20_+_18580176 | 6.69 |
ENSDART00000185310
|
si:dkeyp-72h1.1
|
si:dkeyp-72h1.1 |
| chr25_-_10503043 | 6.69 |
ENSDART00000155404
|
cox8b
|
cytochrome c oxidase subunit 8b |
| chr21_-_40880317 | 6.61 |
ENSDART00000100054
ENSDART00000137696 |
elnb
|
elastin b |
| chr3_-_27868183 | 6.59 |
ENSDART00000185812
|
abat
|
4-aminobutyrate aminotransferase |
| chr2_+_55199721 | 6.54 |
ENSDART00000016143
|
zmp:0000000521
|
zmp:0000000521 |
| chr23_+_21544227 | 6.54 |
ENSDART00000140253
|
arhgef10lb
|
Rho guanine nucleotide exchange factor (GEF) 10-like b |
| chr11_-_1967438 | 6.54 |
ENSDART00000155844
|
nr1d4b
|
nuclear receptor subfamily 1, group D, member 4b |
| chr13_-_7031033 | 6.53 |
ENSDART00000193211
|
CABZ01061524.1
|
|
| chr21_+_25057176 | 6.52 |
ENSDART00000183975
|
zgc:171740
|
zgc:171740 |
| chr11_-_29996344 | 6.50 |
ENSDART00000003712
ENSDART00000126110 |
ace2
|
angiotensin I converting enzyme 2 |
| chr18_+_910992 | 6.48 |
ENSDART00000161206
ENSDART00000167229 |
pkma
|
pyruvate kinase M1/2a |
| chr23_-_25976656 | 6.47 |
ENSDART00000019519
|
ada
|
adenosine deaminase |
| chr25_-_8030425 | 6.42 |
ENSDART00000014964
|
camk1db
|
calcium/calmodulin-dependent protein kinase 1Db |
| chr15_+_19915772 | 6.42 |
ENSDART00000188911
|
map6b
|
microtubule-associated protein 6b |
| chr18_+_46773198 | 6.40 |
ENSDART00000174647
|
CABZ01041495.1
|
|
| chr1_+_14432434 | 6.38 |
ENSDART00000024328
|
slc34a2a
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2a |
| chr4_+_5531583 | 6.36 |
ENSDART00000137500
ENSDART00000042080 |
si:dkey-14d8.6
|
si:dkey-14d8.6 |
| chr17_-_15382704 | 6.33 |
ENSDART00000005313
|
zgc:85722
|
zgc:85722 |
| chr11_-_3552067 | 6.30 |
ENSDART00000163656
|
CAMK2N1
|
si:dkey-33m11.6 |
| chr7_+_22616212 | 6.23 |
ENSDART00000052844
|
cldn7a
|
claudin 7a |
| chr20_-_29418620 | 6.22 |
ENSDART00000172634
|
ryr3
|
ryanodine receptor 3 |
| chr8_-_17771755 | 6.22 |
ENSDART00000063592
|
prkcz
|
protein kinase C, zeta |
| chr4_-_18309917 | 6.19 |
ENSDART00000189084
|
plxnc1
|
plexin C1 |
| chr8_+_48603398 | 6.18 |
ENSDART00000074900
|
zgc:195023
|
zgc:195023 |
| chr17_+_9308425 | 6.17 |
ENSDART00000188283
ENSDART00000183311 |
NPAS3
|
neuronal PAS domain protein 3 |
| chr11_-_11518469 | 6.16 |
ENSDART00000104254
|
krt15
|
keratin 15 |
| chr13_+_24750078 | 6.16 |
ENSDART00000021053
|
col17a1b
|
collagen, type XVII, alpha 1b |
| chr21_-_45588720 | 6.16 |
ENSDART00000186642
ENSDART00000189531 |
LO018363.2
|
|
| chr12_-_13886952 | 6.15 |
ENSDART00000110503
|
adam11
|
ADAM metallopeptidase domain 11 |
| chr11_-_141592 | 6.14 |
ENSDART00000092787
|
cdk4
|
cyclin-dependent kinase 4 |
| chr6_-_14146979 | 6.13 |
ENSDART00000089564
|
cacnb4b
|
calcium channel, voltage-dependent, beta 4b subunit |
| chr3_+_23488652 | 6.13 |
ENSDART00000126282
|
nr1d1
|
nuclear receptor subfamily 1, group d, member 1 |
| chr12_-_10220036 | 6.09 |
ENSDART00000134619
|
mpp2b
|
membrane protein, palmitoylated 2b (MAGUK p55 subfamily member 2) |
| chr1_-_30039331 | 6.09 |
ENSDART00000086935
ENSDART00000143800 |
MARCH4 (1 of many)
|
zgc:153256 |
| chr13_+_30054996 | 6.08 |
ENSDART00000110061
ENSDART00000186045 |
spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr20_+_49119633 | 6.06 |
ENSDART00000151435
|
cd109
|
CD109 molecule |
| chr4_-_4795205 | 6.06 |
ENSDART00000039313
|
zgc:162331
|
zgc:162331 |
| chr5_-_23362602 | 6.05 |
ENSDART00000137120
|
gria3a
|
glutamate receptor, ionotropic, AMPA 3a |
| chr22_+_32120156 | 6.04 |
ENSDART00000149666
|
dock3
|
dedicator of cytokinesis 3 |
| chr21_-_19018455 | 6.02 |
ENSDART00000080256
|
nefma
|
neurofilament, medium polypeptide a |
| chr17_-_52594756 | 6.00 |
ENSDART00000167288
|
si:ch211-173a9.7
|
si:ch211-173a9.7 |
| chr24_+_29381946 | 5.99 |
ENSDART00000189551
|
ntng1a
|
netrin g1a |
| chr25_+_8356707 | 5.94 |
ENSDART00000153708
|
muc5.1
|
mucin 5.1, oligomeric mucus/gel-forming |
| chr8_-_11170114 | 5.93 |
ENSDART00000133532
|
si:ch211-204d2.4
|
si:ch211-204d2.4 |
| chr5_+_23118470 | 5.93 |
ENSDART00000149893
|
nexmifa
|
neurite extension and migration factor a |
| chr16_-_44127307 | 5.91 |
ENSDART00000104583
ENSDART00000151936 ENSDART00000058685 ENSDART00000190830 |
zfpm2a
|
zinc finger protein, FOG family member 2a |
| chr8_-_14049404 | 5.88 |
ENSDART00000093117
|
atp2b3a
|
ATPase plasma membrane Ca2+ transporting 3a |
| chr23_-_16692312 | 5.86 |
ENSDART00000046784
|
fkbp1ab
|
FK506 binding protein 1Ab |
| chr17_+_1063988 | 5.85 |
ENSDART00000160400
|
gchfr
|
GTP cyclohydrolase I feedback regulator |
| chr5_-_67471375 | 5.81 |
ENSDART00000147009
|
si:dkey-251i10.2
|
si:dkey-251i10.2 |
| chr23_-_26532696 | 5.80 |
ENSDART00000124811
ENSDART00000180274 |
si:dkey-205h13.2
|
si:dkey-205h13.2 |
| chr1_-_50838160 | 5.80 |
ENSDART00000163939
ENSDART00000165111 |
zgc:154142
|
zgc:154142 |
| chr3_-_60571218 | 5.80 |
ENSDART00000178981
|
si:ch73-366l1.5
|
si:ch73-366l1.5 |
| chr2_+_38608290 | 5.80 |
ENSDART00000159066
|
cdh24b
|
cadherin 24, type 2b |
| chr13_+_30055171 | 5.76 |
ENSDART00000143581
ENSDART00000132027 |
spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr4_+_11439511 | 5.74 |
ENSDART00000150485
|
pcloa
|
piccolo presynaptic cytomatrix protein a |
| chr6_-_35472923 | 5.74 |
ENSDART00000185907
|
rgs8
|
regulator of G protein signaling 8 |
| chr2_+_51796441 | 5.74 |
ENSDART00000165151
|
crygn1
|
crystallin, gamma N1 |
| chr11_+_41560792 | 5.73 |
ENSDART00000127292
|
kcnab2a
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 a |
| chr8_-_1698155 | 5.71 |
ENSDART00000186159
|
CABZ01065417.1
|
|
| chr21_+_1143141 | 5.70 |
ENSDART00000178294
|
CABZ01086139.1
|
|
| chr11_-_1291012 | 5.68 |
ENSDART00000158390
|
atp2b2
|
ATPase plasma membrane Ca2+ transporting 2 |
| chr9_+_42095220 | 5.68 |
ENSDART00000148317
ENSDART00000134431 |
pcbp3
|
poly(rC) binding protein 3 |
| chr4_-_2196798 | 5.68 |
ENSDART00000110178
ENSDART00000149330 |
kcnc2
|
potassium voltage-gated channel, Shaw-related subfamily, member 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of snai1a
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 15.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 3.8 | 15.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) regulation of lamellipodium morphogenesis(GO:2000392) |
| 3.7 | 14.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 3.2 | 3.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 2.7 | 8.1 | GO:0097237 | cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 2.7 | 21.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 2.6 | 7.8 | GO:0015824 | proline transport(GO:0015824) |
| 2.3 | 6.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 2.3 | 6.8 | GO:0035046 | pronuclear migration(GO:0035046) |
| 2.1 | 12.6 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
| 2.0 | 8.2 | GO:0032812 | copulation(GO:0007620) regulation of epinephrine secretion(GO:0014060) positive regulation of epinephrine secretion(GO:0032812) positive regulation of catecholamine secretion(GO:0033605) penile erection(GO:0043084) epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) prolactin secretion(GO:0070459) |
| 2.0 | 6.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 2.0 | 20.4 | GO:1904071 | presynaptic active zone assembly(GO:1904071) |
| 2.0 | 8.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
| 1.9 | 7.5 | GO:0003245 | growth involved in heart morphogenesis(GO:0003241) cardiac chamber ballooning(GO:0003242) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.9 | 5.6 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 1.8 | 11.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 1.8 | 5.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 1.8 | 8.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
| 1.8 | 14.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
| 1.7 | 5.1 | GO:0014809 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 1.7 | 5.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 1.7 | 6.7 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 1.6 | 4.9 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) L-kynurenine catabolic process(GO:0097053) |
| 1.6 | 25.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 1.6 | 11.2 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
| 1.5 | 7.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) protein localization to axon(GO:0099612) |
| 1.5 | 7.6 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
| 1.5 | 4.5 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 1.5 | 8.9 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
| 1.5 | 11.8 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 1.5 | 5.9 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 1.4 | 4.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) Schwann cell migration(GO:0036135) cardiac neuron differentiation(GO:0060945) cardiac neuron development(GO:0060959) |
| 1.4 | 5.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 1.4 | 4.3 | GO:0014014 | negative regulation of gliogenesis(GO:0014014) |
| 1.4 | 4.3 | GO:0042420 | octopamine biosynthetic process(GO:0006589) dopamine catabolic process(GO:0042420) norepinephrine biosynthetic process(GO:0042421) octopamine metabolic process(GO:0046333) |
| 1.4 | 25.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 1.4 | 9.5 | GO:0090177 | establishment of planar polarity of embryonic epithelium(GO:0042249) establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 1.3 | 10.8 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 1.3 | 5.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 1.3 | 10.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 1.3 | 6.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 1.3 | 14.2 | GO:0032264 | IMP salvage(GO:0032264) |
| 1.3 | 3.9 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) negative regulation of potassium ion transmembrane transport(GO:1901380) negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 1.3 | 6.3 | GO:0003210 | cardiac atrium formation(GO:0003210) |
| 1.2 | 9.9 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 1.2 | 2.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 1.2 | 9.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 1.2 | 7.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 1.2 | 4.9 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 1.2 | 4.9 | GO:0048940 | anterior lateral line nerve glial cell differentiation(GO:0048913) myelination of anterior lateral line nerve axons(GO:0048914) anterior lateral line nerve glial cell development(GO:0048939) anterior lateral line nerve glial cell morphogenesis involved in differentiation(GO:0048940) |
| 1.1 | 8.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 1.1 | 2.3 | GO:0044320 | leptin-mediated signaling pathway(GO:0033210) cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
| 1.1 | 6.8 | GO:0008206 | bile acid biosynthetic process(GO:0006699) bile acid metabolic process(GO:0008206) |
| 1.1 | 3.3 | GO:0050428 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 1.1 | 9.9 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 1.1 | 4.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 1.1 | 4.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 1.1 | 6.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 1.1 | 4.3 | GO:0003161 | cardiac conduction system development(GO:0003161) |
| 1.0 | 13.6 | GO:0046887 | positive regulation of hormone secretion(GO:0046887) |
| 1.0 | 3.1 | GO:0042546 | cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) cellular component macromolecule biosynthetic process(GO:0070589) |
| 1.0 | 8.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 1.0 | 4.1 | GO:0070166 | enamel mineralization(GO:0070166) |
| 1.0 | 5.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 1.0 | 5.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.0 | 4.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.0 | 4.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 1.0 | 4.1 | GO:0006844 | acyl carnitine transport(GO:0006844) |
| 1.0 | 5.0 | GO:0032615 | interleukin-12 production(GO:0032615) regulation of interleukin-12 production(GO:0032655) |
| 1.0 | 3.9 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 1.0 | 10.6 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 1.0 | 3.8 | GO:1900271 | regulation of presynaptic cytosolic calcium ion concentration(GO:0099509) regulation of long-term synaptic potentiation(GO:1900271) |
| 1.0 | 2.9 | GO:0003403 | optic vesicle formation(GO:0003403) |
| 1.0 | 3.8 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 1.0 | 7.6 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 1.0 | 2.9 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.9 | 3.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.9 | 6.5 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) negative regulation of execution phase of apoptosis(GO:1900118) regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.9 | 2.8 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
| 0.9 | 2.8 | GO:0042245 | RNA repair(GO:0042245) |
| 0.9 | 3.7 | GO:0034164 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.9 | 9.1 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.9 | 9.9 | GO:0006798 | polyphosphate metabolic process(GO:0006797) polyphosphate catabolic process(GO:0006798) |
| 0.9 | 19.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.9 | 2.7 | GO:1990359 | detoxification of zinc ion(GO:0010312) manganese ion homeostasis(GO:0055071) stress response to metal ion(GO:0097501) stress response to zinc ion(GO:1990359) |
| 0.9 | 11.7 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.9 | 2.7 | GO:0043606 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.9 | 6.2 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.9 | 6.2 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.9 | 0.9 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.9 | 8.6 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) purinergic receptor signaling pathway(GO:0035587) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.9 | 16.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.8 | 3.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.8 | 3.4 | GO:1904062 | regulation of cation transmembrane transport(GO:1904062) |
| 0.8 | 9.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.8 | 2.5 | GO:0009750 | response to fructose(GO:0009750) |
| 0.8 | 4.9 | GO:0090134 | mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
| 0.8 | 2.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.8 | 6.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.8 | 106.6 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.8 | 13.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.8 | 3.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) isoleucine biosynthetic process(GO:0009097) |
| 0.8 | 4.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.8 | 20.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.8 | 11.0 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.8 | 5.5 | GO:0006833 | water transport(GO:0006833) |
| 0.8 | 8.7 | GO:0061621 | glucose catabolic process(GO:0006007) NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.8 | 4.7 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.8 | 1.6 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) |
| 0.8 | 2.3 | GO:0071312 | response to cocaine(GO:0042220) cellular response to alkaloid(GO:0071312) cellular response to cocaine(GO:0071314) |
| 0.8 | 3.1 | GO:0055107 | Golgi to secretory granule transport(GO:0055107) |
| 0.8 | 10.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.8 | 7.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.8 | 3.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.7 | 8.2 | GO:0098900 | regulation of action potential(GO:0098900) |
| 0.7 | 3.7 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.7 | 2.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.7 | 11.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 | 2.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.7 | 13.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.7 | 36.5 | GO:0006096 | glycolytic process(GO:0006096) |
| 0.7 | 26.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.7 | 1.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.7 | 21.2 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) |
| 0.7 | 2.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 | 1.4 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.7 | 7.0 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.7 | 2.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.7 | 0.7 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
| 0.7 | 1.4 | GO:0051952 | amine transport(GO:0015837) regulation of amine transport(GO:0051952) |
| 0.7 | 8.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.7 | 2.1 | GO:1904377 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.7 | 4.8 | GO:0032475 | otolith formation(GO:0032475) |
| 0.7 | 4.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.7 | 1.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of cyclase activity(GO:0031280) negative regulation of nucleotide metabolic process(GO:0045980) negative regulation of lyase activity(GO:0051350) negative regulation of purine nucleotide biosynthetic process(GO:1900372) negative regulation of purine nucleotide metabolic process(GO:1900543) |
| 0.7 | 2.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host(GO:0044406) adhesion of symbiont to host cell(GO:0044650) |
| 0.7 | 8.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.7 | 6.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.7 | 3.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.7 | 9.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.7 | 2.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.6 | 5.8 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.6 | 2.6 | GO:0070317 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
| 0.6 | 3.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.6 | 5.7 | GO:1902868 | positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) |
| 0.6 | 1.9 | GO:0055057 | neuroblast division(GO:0055057) positive regulation of stem cell proliferation(GO:2000648) |
| 0.6 | 13.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.6 | 3.1 | GO:2000561 | negative regulation of interferon-gamma production(GO:0032689) CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.6 | 1.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.6 | 2.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.6 | 3.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.6 | 3.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.6 | 2.4 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.6 | 2.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.6 | 2.4 | GO:0046440 | lysine catabolic process(GO:0006554) L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.6 | 4.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.6 | 7.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.6 | 2.9 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
| 0.6 | 2.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.6 | 2.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.6 | 3.4 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.6 | 1.7 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.6 | 9.1 | GO:0051899 | membrane depolarization(GO:0051899) |
| 0.6 | 2.8 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
| 0.6 | 5.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 | 1.6 | GO:0072025 | proximal straight tubule development(GO:0072020) distal convoluted tubule development(GO:0072025) late distal convoluted tubule development(GO:0072068) |
| 0.5 | 7.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.5 | 0.5 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
| 0.5 | 2.2 | GO:0090386 | phagosome maturation involved in apoptotic cell clearance(GO:0090386) phagolysosome assembly involved in apoptotic cell clearance(GO:0090387) |
| 0.5 | 4.3 | GO:0006567 | threonine metabolic process(GO:0006566) threonine catabolic process(GO:0006567) |
| 0.5 | 1.6 | GO:0090219 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 3.7 | GO:0046037 | GMP biosynthetic process(GO:0006177) GMP metabolic process(GO:0046037) |
| 0.5 | 2.6 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
| 0.5 | 5.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.5 | 3.6 | GO:2000463 | postsynaptic density assembly(GO:0097107) modulation of excitatory postsynaptic potential(GO:0098815) positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.5 | 3.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.5 | 3.6 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.5 | 1.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.5 | 1.5 | GO:0097435 | fibril organization(GO:0097435) |
| 0.5 | 7.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.5 | 2.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.5 | 2.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.5 | 5.4 | GO:0060291 | excitatory postsynaptic potential(GO:0060079) long-term synaptic potentiation(GO:0060291) chemical synaptic transmission, postsynaptic(GO:0099565) |
| 0.5 | 6.9 | GO:0009251 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.5 | 2.5 | GO:0071881 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway(GO:0071881) |
| 0.5 | 5.9 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.5 | 2.9 | GO:0015864 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.5 | 2.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.5 | 5.4 | GO:0042026 | protein refolding(GO:0042026) |
| 0.5 | 2.4 | GO:0060055 | larval development(GO:0002164) larval heart development(GO:0007508) angiogenesis involved in wound healing(GO:0060055) |
| 0.5 | 6.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.5 | 1.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.5 | 2.9 | GO:0010970 | establishment of localization by movement along microtubule(GO:0010970) |
| 0.5 | 2.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.5 | 1.0 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.5 | 3.3 | GO:0036268 | swimming(GO:0036268) |
| 0.5 | 5.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.5 | 1.9 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.5 | 7.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.5 | 4.2 | GO:1900407 | regulation of cellular response to oxidative stress(GO:1900407) |
| 0.5 | 4.6 | GO:0015810 | acidic amino acid transport(GO:0015800) aspartate transport(GO:0015810) L-glutamate transport(GO:0015813) malate-aspartate shuttle(GO:0043490) |
| 0.5 | 2.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.5 | 4.1 | GO:1901642 | nucleoside transport(GO:0015858) nucleoside transmembrane transport(GO:1901642) |
| 0.5 | 3.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.5 | 1.4 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
| 0.5 | 6.8 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 0.4 | 2.2 | GO:0008592 | regulation of Toll signaling pathway(GO:0008592) |
| 0.4 | 4.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.4 | 4.0 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
| 0.4 | 1.8 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
| 0.4 | 9.8 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.4 | 8.0 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.4 | 1.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.4 | 19.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 | 41.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.4 | 2.6 | GO:0097638 | amino acid import(GO:0043090) L-arginine import(GO:0043091) L-amino acid import(GO:0043092) amino acid import across plasma membrane(GO:0089718) arginine import(GO:0090467) L-arginine import across plasma membrane(GO:0097638) L-arginine transport(GO:1902023) L-arginine import into cell(GO:1902765) amino acid import into cell(GO:1902837) L-arginine transmembrane transport(GO:1903400) arginine transmembrane transport(GO:1903826) |
| 0.4 | 1.8 | GO:0015677 | copper ion import(GO:0015677) |
| 0.4 | 1.3 | GO:0097401 | regulation of cellular pH reduction(GO:0032847) synaptic vesicle lumen acidification(GO:0097401) regulation of synaptic vesicle lumen acidification(GO:1901546) |
| 0.4 | 1.3 | GO:0098529 | neuromuscular junction development, skeletal muscle fiber(GO:0098529) |
| 0.4 | 41.1 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.4 | 1.7 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
| 0.4 | 7.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.4 | 4.3 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
| 0.4 | 1.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.4 | 2.1 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
| 0.4 | 3.4 | GO:0048790 | maintenance of presynaptic active zone structure(GO:0048790) maintenance of synapse structure(GO:0099558) |
| 0.4 | 29.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.4 | 2.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.4 | 2.9 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.4 | 0.4 | GO:0032366 | intracellular sterol transport(GO:0032366) |
| 0.4 | 2.9 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.4 | 2.1 | GO:0048903 | anterior lateral line neuromast hair cell differentiation(GO:0048903) |
| 0.4 | 8.6 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
| 0.4 | 8.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.4 | 5.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.4 | 1.6 | GO:0090036 | positive regulation of protein kinase A signaling(GO:0010739) regulation of protein kinase C signaling(GO:0090036) |
| 0.4 | 2.8 | GO:0010155 | regulation of proton transport(GO:0010155) |
| 0.4 | 3.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 0.4 | 5.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.4 | 4.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.4 | 1.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.4 | 1.2 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.4 | 3.1 | GO:0042214 | carotene metabolic process(GO:0016119) carotene catabolic process(GO:0016121) terpene metabolic process(GO:0042214) terpene catabolic process(GO:0046247) |
| 0.4 | 1.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 2.7 | GO:0086001 | cardiac muscle cell action potential(GO:0086001) |
| 0.4 | 3.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.4 | 3.4 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.4 | 1.5 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.4 | 55.2 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
| 0.4 | 1.1 | GO:0019284 | L-methionine biosynthetic process from S-adenosylmethionine(GO:0019284) |
| 0.4 | 5.1 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.4 | 10.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.4 | 2.1 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.4 | 5.3 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) dendritic spine organization(GO:0097061) |
| 0.4 | 1.1 | GO:0060784 | regulation of cell proliferation involved in tissue homeostasis(GO:0060784) |
| 0.4 | 2.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.4 | 1.8 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.3 | 3.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 | 11.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.3 | 0.7 | GO:0090278 | negative regulation of peptide secretion(GO:0002792) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.3 | 2.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.3 | 2.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.3 | 2.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.3 | 5.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.3 | 9.7 | GO:0070593 | dendrite self-avoidance(GO:0070593) |
| 0.3 | 2.0 | GO:0061437 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
| 0.3 | 2.7 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.3 | 2.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 | 2.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.3 | 9.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.3 | 1.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 6.4 | GO:0043507 | activation of JUN kinase activity(GO:0007257) positive regulation of JUN kinase activity(GO:0043507) |
| 0.3 | 2.3 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.3 | 18.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.3 | 8.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.3 | 1.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 | 5.7 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.3 | 9.8 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.3 | 1.9 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.3 | 18.2 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.3 | 3.7 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.3 | 34.3 | GO:0051260 | protein homooligomerization(GO:0051260) |
| 0.3 | 11.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.3 | 0.3 | GO:0042755 | eating behavior(GO:0042755) |
| 0.3 | 3.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
| 0.3 | 1.5 | GO:0060401 | cytosolic calcium ion transport(GO:0060401) calcium ion transport into cytosol(GO:0060402) |
| 0.3 | 4.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 | 1.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.3 | 5.0 | GO:0008345 | larval locomotory behavior(GO:0008345) larval behavior(GO:0030537) |
| 0.3 | 0.9 | GO:1903673 | mitotic cytokinetic process(GO:1902410) mitotic cleavage furrow formation(GO:1903673) |
| 0.3 | 1.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.3 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.3 | 2.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 | 1.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 1.4 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.3 | 4.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.3 | 17.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.3 | 4.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.3 | 1.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.3 | 1.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.3 | 1.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 | 4.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.3 | 0.8 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) negative regulation of lipoprotein metabolic process(GO:0050748) regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 0.3 | 1.3 | GO:0035678 | neuromast hair cell morphogenesis(GO:0035678) |
| 0.3 | 5.7 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.3 | 5.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.3 | 4.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 | 2.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 1.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.2 | 1.7 | GO:0003315 | heart rudiment formation(GO:0003315) |
| 0.2 | 0.7 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
| 0.2 | 3.7 | GO:0098962 | regulation of postsynaptic neurotransmitter receptor activity(GO:0098962) |
| 0.2 | 0.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
| 0.2 | 33.2 | GO:0007601 | visual perception(GO:0007601) |
| 0.2 | 17.1 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
| 0.2 | 16.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
| 0.2 | 4.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.2 | 1.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.2 | 3.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.2 | 1.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.2 | 0.7 | GO:0034773 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.2 | 6.1 | GO:0009636 | response to toxic substance(GO:0009636) |
| 0.2 | 0.9 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.2 | 18.5 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
| 0.2 | 8.6 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.2 | 3.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.2 | 20.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.2 | 1.6 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
| 0.2 | 1.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 2.4 | GO:0097090 | presynaptic membrane organization(GO:0097090) postsynaptic membrane assembly(GO:0097104) presynaptic membrane assembly(GO:0097105) |
| 0.2 | 5.5 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
| 0.2 | 3.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) |
| 0.2 | 1.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 8.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.2 | 2.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.2 | 1.3 | GO:0038065 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.2 | 3.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.2 | 29.7 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
| 0.2 | 0.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 | 2.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 | 6.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.2 | 0.8 | GO:2000058 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
| 0.2 | 1.7 | GO:0003422 | growth plate cartilage morphogenesis(GO:0003422) chondrocyte intercalation involved in growth plate cartilage morphogenesis(GO:0003428) |
| 0.2 | 9.7 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.2 | 0.6 | GO:0032677 | interleukin-6 production(GO:0032635) interleukin-8 production(GO:0032637) regulation of interleukin-6 production(GO:0032675) regulation of interleukin-8 production(GO:0032677) positive regulation of interleukin-8 production(GO:0032757) |
| 0.2 | 2.7 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.2 | 39.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 3.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 2.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 2.8 | GO:0032881 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) regulation of polysaccharide metabolic process(GO:0032881) regulation of polysaccharide biosynthetic process(GO:0032885) regulation of glycogen metabolic process(GO:0070873) |
| 0.2 | 1.2 | GO:0045176 | asymmetric protein localization(GO:0008105) apical protein localization(GO:0045176) |
| 0.2 | 3.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 3.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 5.9 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.2 | 7.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.2 | 11.9 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.2 | 4.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.2 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 5.4 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
| 0.2 | 1.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 6.0 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
| 0.2 | 0.9 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 1.4 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.2 | 2.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.2 | 1.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 | 0.8 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.2 | 1.0 | GO:0070375 | ERK5 cascade(GO:0070375) regulation of ERK5 cascade(GO:0070376) positive regulation of ERK5 cascade(GO:0070378) |
| 0.2 | 0.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.2 | 2.1 | GO:0045471 | response to ethanol(GO:0045471) |
| 0.2 | 1.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
| 0.2 | 19.1 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.2 | 0.5 | GO:0070293 | renal absorption(GO:0070293) |
| 0.2 | 1.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.2 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.2 | 4.0 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
| 0.2 | 2.1 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 8.1 | GO:0006821 | chloride transport(GO:0006821) |
| 0.2 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 4.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
| 0.2 | 1.1 | GO:0031048 | chromatin silencing by small RNA(GO:0031048) |
| 0.2 | 0.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.2 | 13.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.2 | 3.1 | GO:0060415 | muscle organ morphogenesis(GO:0048644) muscle tissue morphogenesis(GO:0060415) |
| 0.2 | 0.8 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.2 | 0.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.1 | 24.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.1 | 1.1 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.1 | 0.6 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 1.0 | GO:0050795 | regulation of behavior(GO:0050795) |
| 0.1 | 1.5 | GO:0072676 | lymphocyte migration(GO:0072676) |
| 0.1 | 5.4 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.4 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) NAD catabolic process(GO:0019677) pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 | 0.3 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 1.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.8 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.1 | 1.9 | GO:0009583 | phototransduction(GO:0007602) detection of light stimulus(GO:0009583) |
| 0.1 | 3.1 | GO:0008643 | carbohydrate transport(GO:0008643) |
| 0.1 | 0.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.1 | 2.0 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.4 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.3 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.1 | 2.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 2.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.1 | 0.7 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) regulation of DNA-templated transcription in response to stress(GO:0043620) |
| 0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.1 | 1.0 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.1 | 3.0 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
| 0.1 | 1.2 | GO:0022615 | protein import into peroxisome matrix, docking(GO:0016560) protein to membrane docking(GO:0022615) |
| 0.1 | 1.8 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
| 0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 8.5 | GO:0006865 | amino acid transport(GO:0006865) |
| 0.1 | 0.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 0.7 | GO:0061074 | regulation of neural retina development(GO:0061074) |
| 0.1 | 1.7 | GO:0001649 | osteoblast differentiation(GO:0001649) |
| 0.1 | 1.4 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
| 0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 1.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.1 | 1.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.1 | 1.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.1 | 0.4 | GO:1903019 | negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) negative regulation of glycoprotein metabolic process(GO:1903019) |
| 0.1 | 1.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 0.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.1 | 0.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.1 | 2.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.1 | 3.3 | GO:0009190 | cyclic nucleotide biosynthetic process(GO:0009190) |
| 0.1 | 0.9 | GO:0043217 | myelin maintenance(GO:0043217) |
| 0.1 | 1.0 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 | 1.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
| 0.1 | 2.6 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.1 | 5.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.1 | 2.9 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
| 0.1 | 1.3 | GO:0060232 | delamination(GO:0060232) |
| 0.1 | 1.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 2.8 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.1 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 1.0 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 6.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
| 0.1 | 0.6 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.9 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.1 | 2.2 | GO:0045010 | actin nucleation(GO:0045010) |
| 0.1 | 0.6 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 | 0.3 | GO:0034331 | cell junction maintenance(GO:0034331) adherens junction maintenance(GO:0034334) |
| 0.1 | 0.3 | GO:0031113 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) regulation of microtubule polymerization(GO:0031113) positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 | 1.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.1 | 0.7 | GO:0045923 | negative regulation of cholesterol storage(GO:0010887) negative regulation of lipid storage(GO:0010888) positive regulation of fatty acid metabolic process(GO:0045923) |
| 0.1 | 0.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.1 | 0.5 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 | 3.7 | GO:0048675 | axon extension(GO:0048675) |
| 0.1 | 0.3 | GO:0090594 | inflammatory response to wounding(GO:0090594) |
| 0.1 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.3 | GO:0003400 | regulation of COPII vesicle coating(GO:0003400) regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis(GO:0090113) |
| 0.1 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 0.8 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.1 | 0.3 | GO:0031174 | lifelong otolith mineralization(GO:0031174) |
| 0.1 | 2.5 | GO:0007254 | JNK cascade(GO:0007254) |
| 0.1 | 0.6 | GO:0007622 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.1 | 1.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
| 0.1 | 1.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 2.8 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
| 0.1 | 0.5 | GO:0031063 | regulation of histone deacetylation(GO:0031063) regulation of protein deacetylation(GO:0090311) |
| 0.1 | 3.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 2.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.5 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
| 0.1 | 3.5 | GO:0072659 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
| 0.1 | 0.8 | GO:0014831 | vascular endothelial growth factor production(GO:0010573) regulation of vascular endothelial growth factor production(GO:0010574) positive regulation of vascular endothelial growth factor production(GO:0010575) gastro-intestinal system smooth muscle contraction(GO:0014831) esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.7 | GO:0032438 | melanosome organization(GO:0032438) |
| 0.1 | 0.1 | GO:0050869 | negative regulation of B cell proliferation(GO:0030889) negative regulation of B cell activation(GO:0050869) |
| 0.1 | 2.7 | GO:0007626 | locomotory behavior(GO:0007626) |
| 0.1 | 1.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 3.6 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
| 0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.5 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 0.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.1 | 0.4 | GO:0097324 | melanocyte migration(GO:0097324) |
| 0.1 | 1.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 | 0.8 | GO:0030500 | regulation of bone mineralization(GO:0030500) regulation of biomineral tissue development(GO:0070167) |
| 0.1 | 1.1 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.1 | 0.6 | GO:0046683 | response to purine-containing compound(GO:0014074) response to ATP(GO:0033198) response to organophosphorus(GO:0046683) |
| 0.1 | 0.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.1 | 0.7 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 1.4 | GO:0042594 | response to starvation(GO:0042594) |
| 0.0 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.8 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 | 4.0 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.0 | 10.4 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
| 0.0 | 1.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.0 | 6.5 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
| 0.0 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 1.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.7 | GO:1903052 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) positive regulation of cellular protein catabolic process(GO:1903364) |
| 0.0 | 1.5 | GO:0050817 | coagulation(GO:0050817) |
| 0.0 | 2.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 0.7 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
| 0.0 | 0.4 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 | 0.1 | GO:0048660 | regulation of smooth muscle cell proliferation(GO:0048660) negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 | 2.3 | GO:0010506 | regulation of autophagy(GO:0010506) |
| 0.0 | 0.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.0 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.0 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.0 | 0.3 | GO:0032412 | regulation of ion transmembrane transporter activity(GO:0032412) |
| 0.0 | 0.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 1.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.0 | 0.2 | GO:0009409 | response to cold(GO:0009409) |
| 0.0 | 0.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 1.5 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
| 0.0 | 0.8 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 | 1.5 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
| 0.0 | 1.4 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) negative regulation of protein polymerization(GO:0032272) |
| 0.0 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 | 1.7 | GO:1901342 | regulation of vasculature development(GO:1901342) |
| 0.0 | 1.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.1 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.0 | 0.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
| 0.0 | 0.4 | GO:0051904 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.0 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.0 | 0.1 | GO:0010810 | regulation of cell-substrate adhesion(GO:0010810) |
| 0.0 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.1 | GO:0035093 | spermatid nucleus differentiation(GO:0007289) sperm chromatin condensation(GO:0035092) spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.0 | 0.1 | GO:0032652 | interleukin-1 production(GO:0032612) regulation of interleukin-1 production(GO:0032652) |
| 0.0 | 0.9 | GO:0009617 | response to bacterium(GO:0009617) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 12.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 3.0 | 15.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 2.9 | 20.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 2.2 | 33.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 2.1 | 16.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 2.0 | 20.4 | GO:0098982 | GABA-ergic synapse(GO:0098982) |
| 1.7 | 8.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.7 | 11.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 1.6 | 24.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 1.4 | 7.2 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 1.2 | 15.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 1.2 | 6.0 | GO:0005883 | neurofilament(GO:0005883) |
| 1.2 | 14.4 | GO:0044295 | axonal growth cone(GO:0044295) |
| 1.1 | 3.4 | GO:1990745 | EARP complex(GO:1990745) |
| 1.1 | 10.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 1.1 | 7.6 | GO:0033010 | paranodal junction(GO:0033010) |
| 1.1 | 3.2 | GO:0005948 | acetolactate synthase complex(GO:0005948) |
| 1.0 | 5.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.9 | 5.6 | GO:0070695 | FHF complex(GO:0070695) |
| 0.9 | 16.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.9 | 2.7 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.9 | 5.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.8 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) anchored component of the cytoplasmic side of the plasma membrane(GO:0098753) |
| 0.8 | 3.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.8 | 8.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.8 | 18.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
| 0.8 | 7.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.8 | 12.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.7 | 5.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.7 | 24.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.7 | 28.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.7 | 4.6 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.7 | 12.4 | GO:0048788 | cytoskeleton of presynaptic active zone(GO:0048788) |
| 0.6 | 23.1 | GO:0043204 | perikaryon(GO:0043204) |
| 0.6 | 3.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.6 | 2.4 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.6 | 3.6 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
| 0.6 | 2.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.6 | 11.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.6 | 14.1 | GO:0099634 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 0.6 | 1.7 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.5 | 3.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.5 | 1.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.5 | 4.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.5 | 9.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.5 | 9.8 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.5 | 10.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.5 | 3.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.5 | 21.4 | GO:0005861 | troponin complex(GO:0005861) |
| 0.5 | 1.4 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
| 0.5 | 1.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.5 | 7.2 | GO:0005903 | brush border(GO:0005903) |
| 0.4 | 6.2 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.4 | 1.3 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.4 | 5.7 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.4 | 24.9 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.4 | 1.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.4 | 6.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.4 | 7.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.4 | 15.0 | GO:0030426 | growth cone(GO:0030426) |
| 0.4 | 1.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.4 | 22.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.4 | 4.1 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) extrinsic component of presynaptic membrane(GO:0098888) extrinsic component of presynaptic endocytic zone(GO:0098894) |
| 0.4 | 2.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.4 | 2.9 | GO:0016586 | RSC complex(GO:0016586) |
| 0.4 | 7.9 | GO:0043256 | basal lamina(GO:0005605) laminin complex(GO:0043256) |
| 0.3 | 5.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.3 | 1.7 | GO:1990071 | TRAPPII protein complex(GO:1990071) |
| 0.3 | 1.7 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.3 | 1.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.3 | 26.4 | GO:0034703 | cation channel complex(GO:0034703) |
| 0.3 | 2.3 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.3 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.3 | 2.6 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.3 | 1.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.3 | 2.8 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) stereocilium tip(GO:0032426) |
| 0.3 | 2.1 | GO:0030315 | T-tubule(GO:0030315) |
| 0.3 | 6.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.3 | 5.2 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.3 | 1.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) zonula adherens(GO:0005915) |
| 0.3 | 9.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.3 | 2.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor heterodimeric complex(GO:0038039) G-protein coupled receptor complex(GO:0097648) |
| 0.3 | 36.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.3 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 4.4 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.3 | 5.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.3 | 1.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 1.0 | GO:0097519 | DNA recombinase complex(GO:0097519) |
| 0.3 | 2.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.3 | 7.6 | GO:0098978 | glutamatergic synapse(GO:0098978) |
| 0.3 | 8.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 50.4 | GO:0030424 | axon(GO:0030424) |
| 0.2 | 45.5 | GO:0098793 | presynapse(GO:0098793) |
| 0.2 | 19.5 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 2.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 8.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.2 | 1.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 4.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 12.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.2 | 2.1 | GO:0070069 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) cytochrome complex(GO:0070069) |
| 0.2 | 8.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.2 | 6.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.2 | 5.6 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 2.7 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 3.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 2.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
| 0.2 | 3.5 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 2.1 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 2.6 | GO:0044545 | NSL complex(GO:0044545) |
| 0.2 | 5.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.2 | 0.7 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.2 | 6.3 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.2 | 9.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.2 | 61.8 | GO:0043005 | neuron projection(GO:0043005) |
| 0.2 | 3.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 4.1 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.2 | 2.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 2.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 16.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.2 | 2.8 | GO:0031982 | vesicle(GO:0031982) |
| 0.2 | 8.9 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.2 | 7.7 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.2 | 23.1 | GO:0045202 | synapse(GO:0045202) |
| 0.2 | 10.0 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 1.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.4 | GO:0030062 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.1 | 8.8 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 158.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
| 0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 1.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 31.4 | GO:0005764 | lysosome(GO:0005764) |
| 0.1 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 5.1 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 0.9 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.1 | 4.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 3.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.1 | 31.6 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 1.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 6.1 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 1.8 | GO:0030016 | myofibril(GO:0030016) |
| 0.1 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 8.4 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 2.1 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 4.3 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 9.3 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 6.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.1 | 9.5 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 1.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 4.4 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.1 | 0.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 1.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 20.1 | GO:0097708 | intracellular vesicle(GO:0097708) |
| 0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 10.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 3.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 4.5 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 0.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.4 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.1 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 64.0 | GO:0005576 | extracellular region(GO:0005576) |
| 0.0 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 4.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.0 | 0.7 | GO:0001725 | stress fiber(GO:0001725) actomyosin(GO:0042641) contractile actin filament bundle(GO:0097517) |
| 0.0 | 2.3 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) Golgi medial cisterna(GO:0005797) |
| 0.0 | 1.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.7 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.0 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 59.1 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 15.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 4.6 | 13.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 4.5 | 26.9 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 4.0 | 20.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 3.6 | 10.7 | GO:0080132 | fatty acid alpha-hydroxylase activity(GO:0080132) |
| 2.7 | 13.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 2.6 | 23.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 2.3 | 9.1 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 2.1 | 10.4 | GO:0032052 | bile acid binding(GO:0032052) |
| 2.0 | 4.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 2.0 | 9.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 1.9 | 3.8 | GO:0005499 | vitamin D binding(GO:0005499) |
| 1.9 | 24.8 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 1.9 | 9.5 | GO:0031420 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
| 1.8 | 12.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 1.8 | 7.1 | GO:0005463 | UDP-glucuronic acid transmembrane transporter activity(GO:0005461) UDP-N-acetylgalactosamine transmembrane transporter activity(GO:0005463) |
| 1.7 | 17.5 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.7 | 8.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.7 | 5.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 1.7 | 8.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 1.6 | 14.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 1.5 | 30.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 1.5 | 10.5 | GO:0071916 | dipeptide transporter activity(GO:0042936) dipeptide transmembrane transporter activity(GO:0071916) |
| 1.5 | 13.4 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 1.4 | 10.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 1.4 | 4.3 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
| 1.4 | 11.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 1.3 | 10.8 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 1.3 | 12.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 1.3 | 4.0 | GO:0034618 | arginine binding(GO:0034618) |
| 1.3 | 23.8 | GO:0098882 | structural constituent of presynaptic active zone(GO:0098882) |
| 1.3 | 7.9 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) glucose binding(GO:0005536) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 1.3 | 14.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 1.3 | 3.8 | GO:0031530 | gonadotropin hormone-releasing hormone activity(GO:0005183) gonadotropin-releasing hormone receptor binding(GO:0031530) |
| 1.3 | 5.1 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 1.3 | 104.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 1.2 | 8.6 | GO:0000254 | C-4 methylsterol oxidase activity(GO:0000254) |
| 1.2 | 17.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.2 | 6.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 1.1 | 33.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 1.1 | 4.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 1.1 | 3.3 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 1.1 | 4.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 1.1 | 5.4 | GO:0031769 | glucagon receptor binding(GO:0031769) |
| 1.1 | 7.6 | GO:0098809 | nitrite reductase activity(GO:0098809) |
| 1.1 | 6.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 1.1 | 3.2 | GO:0003984 | acetolactate synthase activity(GO:0003984) |
| 1.1 | 6.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 1.0 | 13.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 1.0 | 4.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 1.0 | 12.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 1.0 | 4.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 1.0 | 3.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 1.0 | 9.8 | GO:0031433 | telethonin binding(GO:0031433) FATZ binding(GO:0051373) |
| 1.0 | 4.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 1.0 | 14.6 | GO:0031682 | G-protein gamma-subunit binding(GO:0031682) |
| 0.9 | 16.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
| 0.9 | 3.7 | GO:0017020 | myosin phosphatase regulator activity(GO:0017020) |
| 0.9 | 11.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.9 | 4.6 | GO:0031841 | neuropeptide Y receptor binding(GO:0031841) type 2 neuropeptide Y receptor binding(GO:0031843) |
| 0.9 | 2.7 | GO:0019767 | immunoglobulin receptor activity(GO:0019763) IgE receptor activity(GO:0019767) |
| 0.9 | 6.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.9 | 9.9 | GO:0004309 | exopolyphosphatase activity(GO:0004309) |
| 0.9 | 3.6 | GO:0004134 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
| 0.9 | 1.8 | GO:0043121 | neurotrophin binding(GO:0043121) |
| 0.9 | 4.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.9 | 8.9 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.9 | 6.2 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
| 0.9 | 5.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.9 | 9.5 | GO:0030172 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
| 0.9 | 16.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.9 | 4.3 | GO:0008743 | L-threonine 3-dehydrogenase activity(GO:0008743) |
| 0.9 | 3.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.8 | 5.9 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
| 0.8 | 7.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.8 | 7.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.8 | 9.1 | GO:0052812 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.8 | 2.5 | GO:0038046 | enkephalin receptor activity(GO:0038046) |
| 0.8 | 4.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.8 | 5.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.8 | 9.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.8 | 4.0 | GO:0038131 | neuregulin receptor activity(GO:0038131) neuregulin binding(GO:0038132) |
| 0.8 | 4.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.8 | 6.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.8 | 2.3 | GO:0016496 | substance P receptor activity(GO:0016496) |
| 0.8 | 6.1 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.8 | 2.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.7 | 8.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.7 | 9.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.7 | 8.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.7 | 24.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.7 | 13.5 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.7 | 2.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.7 | 7.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.7 | 2.8 | GO:0043734 | oxidative DNA demethylase activity(GO:0035516) DNA-N1-methyladenine dioxygenase activity(GO:0043734) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
| 0.7 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.7 | 2.7 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.7 | 41.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.7 | 1.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.7 | 7.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.7 | 4.7 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.7 | 6.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.7 | 3.3 | GO:0008184 | phosphorylase activity(GO:0004645) glycogen phosphorylase activity(GO:0008184) |
| 0.7 | 4.6 | GO:0015250 | water channel activity(GO:0015250) |
| 0.6 | 1.9 | GO:0047173 | phosphatidylcholine-retinol O-acyltransferase activity(GO:0047173) |
| 0.6 | 3.2 | GO:0030504 | inorganic diphosphate transmembrane transporter activity(GO:0030504) |
| 0.6 | 1.9 | GO:0046978 | TAP1 binding(GO:0046978) |
| 0.6 | 32.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.6 | 11.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.6 | 6.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.6 | 29.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.6 | 3.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.6 | 3.7 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.6 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.6 | 3.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.6 | 17.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.6 | 2.4 | GO:0047464 | heparosan-N-sulfate-glucuronate 5-epimerase activity(GO:0047464) |
| 0.6 | 4.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.6 | 1.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.6 | 5.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.6 | 4.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.6 | 3.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.6 | 3.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.6 | 3.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.6 | 4.0 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.6 | 1.7 | GO:0004422 | hypoxanthine phosphoribosyltransferase activity(GO:0004422) |
| 0.5 | 3.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.5 | 18.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.5 | 7.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.5 | 7.6 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.5 | 25.1 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.5 | 3.2 | GO:0008126 | acetylesterase activity(GO:0008126) |
| 0.5 | 2.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.5 | 5.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.5 | 13.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.5 | 14.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.5 | 6.3 | GO:0043495 | protein anchor(GO:0043495) |
| 0.5 | 5.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.5 | 3.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.5 | 2.1 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.5 | 1.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.5 | 1.5 | GO:0031704 | apelin receptor binding(GO:0031704) |
| 0.5 | 4.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.5 | 9.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.5 | 6.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.5 | 2.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.5 | 1.9 | GO:0004649 | poly(ADP-ribose) glycohydrolase activity(GO:0004649) |
| 0.5 | 4.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.5 | 6.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.5 | 15.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.5 | 1.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.5 | 10.2 | GO:0015379 | cation:chloride symporter activity(GO:0015377) potassium:chloride symporter activity(GO:0015379) |
| 0.5 | 2.3 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.4 | 12.1 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.4 | 8.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.4 | 2.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) |
| 0.4 | 4.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.4 | 4.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.4 | 1.8 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.4 | 5.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.4 | 1.8 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.4 | 4.4 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.4 | 1.3 | GO:0042806 | fucose binding(GO:0042806) |
| 0.4 | 12.1 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.4 | 2.2 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
| 0.4 | 2.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.4 | 3.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.4 | 3.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.4 | 12.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.4 | 2.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.4 | 2.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.4 | 1.7 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.4 | 2.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.4 | 2.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.4 | 1.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.4 | 3.2 | GO:0008506 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.4 | 8.7 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.4 | 3.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.4 | 1.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.4 | 4.6 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.4 | 2.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.4 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.4 | 5.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.4 | 17.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.4 | 1.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.4 | 8.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.4 | 1.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.4 | 2.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.4 | 2.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.4 | 2.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.4 | 4.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.4 | 5.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.4 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.4 | 9.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.4 | 17.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.4 | 9.5 | GO:0010857 | protein kinase C activity(GO:0004697) calcium-dependent protein kinase C activity(GO:0004698) calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.4 | 5.6 | GO:0005344 | oxygen transporter activity(GO:0005344) oxygen binding(GO:0019825) |
| 0.3 | 8.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.3 | 1.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.3 | 1.0 | GO:1990238 | double-stranded DNA endodeoxyribonuclease activity(GO:1990238) |
| 0.3 | 14.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.3 | 3.1 | GO:0003834 | beta-carotene 15,15'-monooxygenase activity(GO:0003834) carotenoid dioxygenase activity(GO:0010436) |
| 0.3 | 8.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.3 | 1.0 | GO:0004777 | succinate-semialdehyde dehydrogenase (NAD+) activity(GO:0004777) succinate-semialdehyde dehydrogenase [NAD(P)+] activity(GO:0009013) |
| 0.3 | 1.0 | GO:0047777 | (3S)-citramalyl-CoA lyase activity(GO:0047777) |
| 0.3 | 1.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.3 | 21.7 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.3 | 3.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 3.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.3 | 42.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.3 | 6.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.3 | 5.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.3 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.3 | 4.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.3 | 10.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.3 | 3.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 6.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
| 0.3 | 8.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.3 | 1.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.3 | 3.9 | GO:0015081 | sodium ion transmembrane transporter activity(GO:0015081) |
| 0.3 | 4.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 3.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 9.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 7.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.3 | 4.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.3 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.3 | 8.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.3 | 11.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.3 | 3.4 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
| 0.3 | 5.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 5.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.3 | 1.9 | GO:0019840 | retinoid binding(GO:0005501) isoprenoid binding(GO:0019840) |
| 0.3 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.3 | 6.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.3 | 3.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.3 | 2.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 2.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.3 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.3 | 5.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.3 | 32.1 | GO:0015293 | symporter activity(GO:0015293) |
| 0.2 | 6.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.2 | 1.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 6.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.2 | 1.2 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 2.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 2.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.2 | 3.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.2 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 4.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 34.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.2 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.2 | 1.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 3.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 0.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.2 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.2 | 0.9 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.2 | 6.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.2 | 1.1 | GO:0098631 | C-X3-C chemokine binding(GO:0019960) protein binding involved in cell adhesion(GO:0098631) protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 1.1 | GO:0070004 | cysteine-type exopeptidase activity(GO:0070004) |
| 0.2 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 0.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.2 | 2.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 1.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.2 | 1.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.2 | 17.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 1.3 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 2.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 1.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.2 | 3.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) histone acetyltransferase activity (H3-K23 specific)(GO:0043994) |
| 0.2 | 3.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.2 | 70.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.2 | 5.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.2 | 1.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.2 | 0.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.2 | 4.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 5.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
| 0.2 | 0.8 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 9.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 3.8 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.2 | 1.7 | GO:0004096 | catalase activity(GO:0004096) |
| 0.2 | 13.4 | GO:0005496 | steroid binding(GO:0005496) |
| 0.2 | 1.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.2 | 5.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.2 | 1.1 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
| 0.2 | 1.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 15.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) |
| 0.2 | 2.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 9.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.2 | 1.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.2 | 1.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 6.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.2 | 5.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 7.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.2 | 2.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 1.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.2 | 1.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 2.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.2 | 1.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 1.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 2.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 2.3 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 1.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 0.6 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
| 0.1 | 1.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 9.1 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.1 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.6 | GO:0072570 | ADP-D-ribose binding(GO:0072570) mono-ADP-D-ribose binding(GO:0072571) |
| 0.1 | 1.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.1 | 3.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 1.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.1 | 1.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.1 | 5.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 0.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.1 | 2.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 26.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 1.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 1.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.4 | GO:0070224 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) sulfide:quinone oxidoreductase activity(GO:0070224) |
| 0.1 | 1.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 1.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.1 | 1.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 14.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 1.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 5.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 4.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 2.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 1.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 2.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
| 0.1 | 2.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 11.0 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.1 | 1.3 | GO:0048018 | receptor activator activity(GO:0030546) receptor agonist activity(GO:0048018) |
| 0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 5.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 1.1 | GO:0072542 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
| 0.1 | 1.7 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
| 0.1 | 1.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 3.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 1.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 3.8 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
| 0.1 | 1.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.1 | 3.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 1.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 8.4 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 73.5 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.1 | 0.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 0.1 | 1.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.3 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.1 | 0.3 | GO:0033745 | L-methionine-(R)-S-oxide reductase activity(GO:0033745) |
| 0.1 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 1.3 | GO:0042805 | actinin binding(GO:0042805) muscle alpha-actinin binding(GO:0051371) alpha-actinin binding(GO:0051393) |
| 0.1 | 1.6 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
| 0.1 | 23.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.1 | 4.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.1 | 8.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.1 | 2.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 1.0 | GO:0045134 | guanosine-diphosphatase activity(GO:0004382) uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 0.6 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 1.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 3.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 10.3 | GO:0005543 | phospholipid binding(GO:0005543) |
| 0.1 | 1.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 1.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
| 0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 8.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.1 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 2.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 2.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.0 | 2.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.0 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.1 | GO:0099528 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 0.0 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.0 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.0 | 1.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.0 | 1.5 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.0 | 0.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.0 | 7.6 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.0 | 0.4 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.0 | 3.2 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 1.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 2.2 | GO:0015079 | potassium ion transmembrane transporter activity(GO:0015079) |
| 0.0 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.0 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 1.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.0 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 1.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 1.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.1 | GO:0004997 | thyrotropin-releasing hormone receptor activity(GO:0004997) |
| 0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.0 | 7.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.6 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.0 | 0.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.7 | GO:0004620 | phospholipase activity(GO:0004620) |
| 0.0 | 0.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 19.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.9 | 39.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.9 | 22.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.8 | 8.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.8 | 15.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.7 | 4.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.7 | 5.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.7 | 4.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.6 | 5.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.6 | 19.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.5 | 8.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.5 | 7.4 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.5 | 5.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 10.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.5 | 3.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.4 | 2.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.4 | 15.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.4 | 4.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.4 | 6.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.3 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.3 | 5.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.3 | 1.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.3 | 2.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.3 | 2.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 4.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 6.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 18.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 1.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 1.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 9.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 2.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 4.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 3.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 3.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 2.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 2.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 11.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 2.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 2.2 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 1.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 0.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
| 0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 9.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 1.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 2.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 26.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 2.5 | 2.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 2.0 | 20.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 1.8 | 5.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 1.6 | 11.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 1.5 | 4.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 1.5 | 22.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 1.3 | 7.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 1.2 | 8.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 1.1 | 5.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 1.1 | 4.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.1 | 5.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.9 | 12.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.9 | 1.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.8 | 8.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.8 | 13.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.8 | 27.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.8 | 6.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.7 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.7 | 12.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.7 | 6.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.7 | 6.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.7 | 10.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.6 | 4.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.6 | 5.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.5 | 4.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.5 | 7.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.5 | 14.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.5 | 3.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.5 | 3.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.5 | 9.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.5 | 6.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.5 | 6.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.5 | 22.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.5 | 2.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.5 | 2.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.5 | 3.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.4 | 7.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.4 | 16.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.4 | 5.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.4 | 13.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.4 | 9.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 2.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.4 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.4 | 2.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.4 | 4.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.4 | 1.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 4.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.3 | 1.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.3 | 7.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.3 | 2.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.3 | 2.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.3 | 1.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 22.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.3 | 2.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.3 | 3.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 4.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.3 | 13.0 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.3 | 4.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.3 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.3 | 3.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.3 | 2.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.2 | 2.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.2 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 3.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 3.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.2 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.2 | 13.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.2 | 6.7 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 0.2 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 3.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.2 | 2.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.2 | 3.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 2.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 2.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 2.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 6.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 11.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 2.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 3.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 4.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 1.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 2.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 2.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 0.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 2.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 1.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.0 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.1 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
| 0.0 | 0.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 0.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |